Trials / Completed
CompletedNCT02129998
The Role of Progesterone and PIF for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology
The Role of Luteal Progesterone and Preimplantation Factor (PIF) for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 873 (actual)
- Sponsor
- Regionshospitalet Viborg, Skive · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to achieve a more profound understanding of the endocrine alteration in luteal progesterone level after gonadotrophin stimulated IVF/ICSI cycles and to explore the optimal progesterone level needed for securing implantation and development of early pregnancy. The second part of the project will determine the value of Preimplantation Factor (PIF) measurement in embryo culture medium as a possible tool for improved embryo selection and the use of PIF as an early pregnancy serum marker for healthy implantation and embryo development. IVF: In vitro fertilisation, ICSI: Intracytoplasmic sperm injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | IVF/ICSI treatment |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2017-07-01
- Completion
- 2017-10-01
- First posted
- 2014-05-02
- Last updated
- 2017-10-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02129998. Inclusion in this directory is not an endorsement.